{"version":"1.0","provider_name":"PRISM BioLab","provider_url":"https:\/\/prismbiolab.com\/ja","title":"Prostate Cancer and Radiopharmaceuticals of 177Lu, 225Ac and 213Bi - PRISM BioLab","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"d1CtXxdHV3\"><a href=\"https:\/\/prismbiolab.com\/ja\/2390-2\/\">Prostate Cancer and Radiopharmaceuticals of 177Lu, 225Ac and 213Bi<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/prismbiolab.com\/ja\/2390-2\/embed\/#?secret=d1CtXxdHV3\" width=\"600\" height=\"338\" title=\"&#8220;Prostate Cancer and Radiopharmaceuticals of 177Lu, 225Ac and 213Bi&#8221; &#8212; PRISM BioLab\" data-secret=\"d1CtXxdHV3\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/prismbiolab.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"Prostate-specific membrane antigen (PSMA) is a promising target to achieve a selective delivery to prostate cancer.1) Even though its significance in cancer pharmacology is scarce, radiopharmaceuticals have been taken it as the target for the therapy and diagnostic purposes. PSMA targeting is the legendary story of radiopharmaceutical discovery and development and it is of high [&hellip;]","thumbnail_url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg","thumbnail_width":1122,"thumbnail_height":1097}